It makes me sad when I read of other patients relapsing after battling so hard, but I know that is an aspect of the multiple myeloma world that we all face. Right now, I am in remission but I know that sometime in the future I, too, will relapse. It is comforting to know that there are many new drugs in the pipeline for multiple myeloma and that two new drugs are on schedule to be approved in 2012 in the United States.
When I was undergoing my stem cell transplant, one of my physician’s assistants told my husband and me to remember that all the longevity estimates for MM patients are based on history and to keep in mind that with the advances being made, treatments are becoming more effective in dealing with the disease. Those were reassuring words and I have thought about them many times.
In an earlier post, I mentioned a seminar I had the good fortune to attend in Seattle at Fred Hutchinson Cancer Research Center moderated by Andrew Schorr of Patient Power. This seminar featured William Bensinger, MD, Director, Autologous Marrow Transplants at Seattle Cancer Care Alliance and Noopur Raje, MD, Director, Center for Multiple Myeloma at Massachusetts General Hospital. Here is a link to a video of the seminar:
I am including it again because I think it is important and may provide encouragement to my fellow multiple myeloma patients and readers. My husband, daughter and I came away from this seminar feeling heartened and we were filled with hope for the future.